Form 8-K - Current report:
SEC Accession No. 0001193125-17-235179
Filing Date
2017-07-25
Accepted
2017-07-25 17:26:03
Documents
2
Period of Report
2017-07-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d417513d8k.htm 8-K 15256
2 EX-99.1 d417513dex991.htm EX-99.1 26218
  Complete submission text file 0001193125-17-235179.txt   42533
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 17981181
SIC: 2836 Biological Products, (No Diagnostic Substances)